About the bill
- Full Title
To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Subject Areas
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 4384 — 112th Congress: Patient Safety and Drug Labeling Improvement Act. Retrieved from https://www.govtrack.us/congress/bills/112/hr4384
“H.R. 4384 — 112th Congress: Patient Safety and Drug Labeling Improvement Act.” www.GovTrack.us. 2012. April 30, 2016 <https://www.govtrack.us/congress/bills/112/hr4384>
|title=H.R. 4384 (112th)
|accessdate=April 30, 2016
|author=112th Congress (2012)
|date=April 18, 2012
|quote=Patient Safety and Drug Labeling Improvement Act